Mao Okada

Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization

Yutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki et al. · Hepatology Research · 2017 · 69 citations

Medicine, Oncology, Surgery +17

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma

Hitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi et al. · PLoS ONE · 2018 · 65 citations · Full text

Medicine, Oncology, Radiology +17

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki et al. · Journal of Gastroenterology and Hepatology · 2019 · 63 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma

Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki et al. · PLoS ONE · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +14

<i>Wisteria floribunda</i> agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus

Yutaka Yasui, Masayuki Kurosaki, Yasuyuki Komiyama et al. · Hepatology Research · 2018 · 50 citations

Medicine, Oncology, Pharmacology +17